Arrowhead Pharmaceuticals, Inc. (LON:0HI3)

Arrowhead Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is October - September.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 9, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Market Cap	6,256	3,485	1,794	2,147	2,608	4,850
Market Cap Growth	199.07%	94.27%	-16.45%	-17.66%	-46.23%	47.75%
Enterprise Value	6,090	3,472	1,942	2,136	2,401	4,593
PE Ratio	41.63	-3449.00	-3.87	-13.99	-19.79	-45.90
PS Ratio	7.72	5.64	678.45	11.98	14.40	47.10
PB Ratio	14.96	10.04	13.19	10.63	8.79	15.93
P/TBV Ratio	14.36	9.90	12.70	10.57	8.74	15.84
P/FCF Ratio	26.15	29.83	-3.99	-8.72	-18.54	44.08
P/OCF Ratio	24.81	26.07	-5.21	-18.74	-25.73	38.02
EV/Sales Ratio	7.47	5.62	734.62	11.92	13.26	44.61
EV/EBITDA Ratio	23.84	38.13	-4.48	-14.90	-19.18	-43.82
EV/EBIT Ratio	27.13	47.41	-4.34	-13.99	-18.06	-41.39
EV/FCF Ratio	25.45	29.72	-4.32	-8.68	-17.07	41.75
Debt / Equity Ratio	1.21	1.44	4.43	1.30	0.19	0.06
Debt / EBITDA Ratio	2.12	6.00	-1.46	-1.99	-0.48	-0.18
Debt / FCF Ratio	2.14	4.68	-1.41	-1.16	-0.43	0.17
Net Debt / Equity Ratio	-0.17	-0.10	1.08	-0.07	-0.74	-0.84
Net Debt / EBITDA Ratio	-0.30	-0.39	-0.34	0.11	1.75	2.43
Net Debt / FCF Ratio	-0.31	-0.30	-0.33	0.06	1.56	-2.32
Asset Turnover	0.83	0.66	0.00	0.33	0.35	0.22
Quick Ratio	2.89	4.03	6.34	3.83	2.72	2.58
Current Ratio	3.38	4.86	6.74	3.95	2.92	2.62
Return on Equity (ROE)	75.50%	8.67%	-254.98%	-59.33%	-42.67%	-32.36%
Return on Assets (ROA)	21.04%	4.55%	-62.81%	-28.51%	-26.02%	-24.18%
Return on Invested Capital (ROIC)	54.20%	13.40%	-182.08%	-79.62%	-64.84%	-60.11%
Return on Capital Employed (ROCE)	27.62%	8.83%	-70.85%	-33.80%	-31.97%	-28.51%
Earnings Yield	2.40%	-0.03%	-25.81%	-7.15%	-5.05%	-2.18%
FCF Yield	3.82%	3.35%	-25.08%	-11.47%	-5.39%	2.27%
Buyback Yield / Dilution	-2.07%	-5.78%	-17.92%	-0.11%	-0.15%	-0.17%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.